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Abstract The management of a bile duct injury detected during laparoscopic cholecystectomy is still under discussion. An
end-to-end anastomosis (with or without T-tube drainage) in peroperative detected bile duct injury has been reported to be
associated with stricture formation of the anastomosis area and recurrent jaundice. Between 1991 and 2005, 56 of a total of
500 bile duct injury patients were referred for treating complications after a primary end-to-end anastomosis. After referral,
43 (77%) patients were initially treated endoscopically or by percutaneous transhepatic stent placement (n=3; 5%). After a
mean follow-up of 7±3.3 years, 37 patients (66%) were successfully treated with dilatation and endoscopically placed
stents. One patient died due to a treatment-related complication. A total of 18 patients (32%) underwent a
hepaticojejunostomy. Postoperative complications occurred in three patients (5%) without hospital mortality. These data
confirm that end-to-end anastomosis might be considered as a primary treatment for peroperative detected transection of the
bile duct without extensive tissue loss. Complications (stricture or leakage) can be adequately managed by endoscopic or
percutaneous drainage the majority of patients (66%) and reconstructive surgery after complicated end-to-end anastomosis
is a procedure with relative low morbidity and no mortality.
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Introduction
Bile duct injury (BDI) after laparoscopic cholecystectomy
(LC) is still a major problem in current surgical practice. BDI
is associated with reduced survival, increased morbidity, and
poor long-term quality of life (QoL).
1,2 The incidence of
BDI at laparoscopic cholecystectomy has been reported
between 0.3 to 1.4%,
3–5 depending on the criteria used to
define the injury as well as the study population. Of these
injuries, one-third is detected during the procedure.
6 Mea-
sures to prevent and recognize BDI are outlined in many
publications.
6–8,9–11 The optimal treatment strategy and
short- and long-term outcome has been published exten-
sively.
12–14 Controversy exists however about the manage-
ment of peroperative detected BDI. The most important
factor is the extent of tissue loss of the common bile duct, but
also severity of inflammation and the size and diameter of
the proximal duct. The peroperative management range from
simple drainage and referral to a tertiary center to an end-to-
end anastomosis (EEA) (duct to duct, with or without T-tube
drainage) or a hepaticojejunostomy (HJ).
It has been suggested that EEA is associated with a
relative high stricture rate up to 70–80% and consequently
a high incidence of secondary repair.
15 Therefore, many
tertiary centers prefer to perform a HJ instantly. A
secondary repair after EEA should be associated with an
increased risk of postoperative complications as the
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16,17 Others, however,
consider EEA as a relative simple definitive repair, and also
an optimal initial drainage procedure before reconstructive
surgery in a secondary setting.
18 Reports on large consec-
utive series to analyze the outcome of EEA are scary
because this procedure is generally not performed in
referral centers. One should realize that patients referred
to such a center after previous EEA elsewhere are a
negative selection of the EEA population. So far, a
systematic analysis of a large group of patients with an
EEA has not been performed and therefore this study was
conducted.
The aim of the present study was to analyze short- and
long-term outcome in patients who are referred after failure
of a primary EEA.
Patients and Methods
Patients Cohort and Data Collection
Between January 1991 and January 2006, 500 consecutive
patients were referred to the Academic Medical Center
(AMC) in Amsterdam for the management of a BDI after
cholecystectomy. Patient data was induced in a prospective
database. All types of BDI were included, also minor
injuries such as leakage from the cystic duct or ducts of
Luschka. To define the location of BDI, the Bismuth
classification was used.
18 For the present study, the medical
charts of all patients who underwent a primary EEA were
retrospectively reviewed to analyze the initial operation
reports and clinical data.
Data from the referring hospital included: indication for
cholecystectomy, type of initial procedure, location of
injury, type of repair including the use of a T-tube, the
postoperative diagnostic interventions, and the therapeutic
interventions before referral. Data from the present center
included: symptoms at referral, diagnostic work-up, type of
treatment, short-term, and long-term complications.
Endoscopic, Radiological, and Surgical Treatment
for complicated EEA
Endoscopic treatment was performed by balloon dilatation
or catheter dilatation before stent placement. The biliary
stent is placed over the guide wire bridging the stenosis.
Two or more stents were inserted if possible. For multiple
stent insertion, an endoscopic sphincterotomy was per-
formed to facilitate stent placement. Stents were replaced
after 6 weeks and subsequently exchanged every 3 months
to avoid cholangitis.
Percutaneous transhepatic catheterization was performed
by injecting the contrast medium from the right intercostal
approach. A right or left approach for the percutaneous
transhepatic biliary drainage was chosen depending on
ultrasound images illustrating the biliary anatomy, and the
possibility of puncturing a dilated intrahepatic bile duct.
Catheterization of intrahepatic bile ducts was performed in
standard fashion. A guide wire was advanced through the
biliary stricture into the duodenum. When this was
achieved, a biliary drainage catheter was inserted. All
drainage procedures were performed with the administra-
tion of broad-spectrum antibiotics.
In case of a surgical reconstruction, the procedure was
performed via a Roux-en-Y hepaticojejunostomy. The
stricture in the CBD is transected and the hilar plate is
opened. The hepatic ducts of different segmental bile ducts
are mobilized and from there opened over the left hepatic
duct. Intrahepatic segmental ducts are mobilized and if
possible sutured together before one or two jejunal
anastomosis are made. A closed suction drain is placed
during operation and removed 24–48 hours after surgery.
Percutaneous transhepatic drains, when inserted before
surgery are left in place and removed after 10 days till
6 weeks, depending on the clinical course, the level of
anastomosis and the surgeons’ preference.
Outcome
Follow-up data was obtained through outpatient records
and the records of the general practitioner. The outcome of
treatment was analyzed by the number complications and
late restenosis during follow-up. Failure of treatment was
defined as recurrent stenosis after stent therapy followed by
surgery or recurrent stenosis after surgical reconstruction
followed by additional therapy.
Statistical Analysis
Data from patient characteristics, management, and out-
come show descriptive statistics in number of patients and
percentages. Mean and median values are given with a
minimum and maximum. Long-term stricture-free survival
was analyzed by Kaplan Meier Survival Analysis. Data
analyses were performed using SPSS® software (SPSS,
Chicago, Illinois, USA).
Results
Patients’ Characteristics at Referral
The referral pattern of BDI patients (n=500) throughout the
last 15 years are summarized in Fig. 1. From the total of
500 patients, 56 (11.5%) underwent a primary EEA. Patient
characteristics are listed in Table 1. The laparoscopic
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patients. An open cholecystectomy was performed in eight
patients (14%). In 49 patients (88%), the anastomosis was
made over a T-tube. The tube was removed at the referring
hospital or at the AMC after a mean of 52 days (range
2–145 days).
After the primary EEA, 19 patients (34%) underwent
other therapeutical interventions before referral (Table 2).
These patients underwent a range of one to three procedures
before referral (median 2). The interventions included a
relaparotomy in two patients (4%), percutaneous drainage
of fluid collections in five patients (9%), endoscopicially
placed stents in 12 patients (21%), a papillotomy in nine
patients (16%), and percutaneous transhepatic drainage in
two patients (4%). The median interval from the primary
EEA to referral was 16 weeks (range 0–141 weeks). At
referral, a biliary stricture was diagnosed in 38 patients
(68%); in 10 patients (18%), bile leakage was diagnosed and
combination of both in eight patients (14%). Symptoms at
referral were cholestasis (n=14, 25%), cholangitis (n=10,
18%), and abdominal pain (n=15, 27%). Three patients
were referred because of uncontrolled sepsis (n=2) and
peritonitis (n=1). According to the Bismuth classification,
the majority of injuries (leakage of stricture) (n=47, 84%)
was located below the bifurcation. In nine patients (16%),
the injury (mostly strictures) involved the bifurcation or the
right or left hepatic duct (i.e., Bismuth classification grades
IV and V).
Management after Referral
Diagnostic work-up was performed by CT-scan (n=9;
16%), endoscopic cholangiography (n=38; 68%), and
transhepatic cholangiography (n=9; 16%). The definitive
treatment of BDI patients after EEA is shown in the flow
diagram (Fig. 3). After work-up, three patients (5.3%) were
treated with percutaneous transhepatic cholangiographic
drainage (PTCD) and 40 patients (71.4%) were treated
endoscopically. Thirteen patients (23%) underwent recon-
structive surgery after work-up; eight patients because of a
complete stenosis of the CBD, in three patients reconstruc-
tive surgery was performed after failure of stent therapy at
the referring hospital and in two patients because of a
percutaneous fistula and persistent bile leakage.
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Figure 1 Referred patients for
treatment of bile duct injury.
Total number of referred patients
(red), patients referred after a
primary end to end anastomosis
(blue), and patients referred after
a primary biliodigestive recon-
struction (green).
Table 1 Patient Characteristics
Primary EEA
n=56 %
Age at cholecystectomy
Mean (years) 52
Gender
Female 43 77
Indication for cholecystectomy
Symptomatic cholelithiasis 45 80
Cholecystitis 5 9
Cholecystitis a froid 6 1
Type of initial operation
Open procedure 8 14
Laparoscopic to open
procedure
48 86
Anastomosis over T-tube 49 88
Duration of T-tube in situ
Days, median (range) 42(2–145)
298 J Gastrointest Surg (2007) 11:296–302Radiological and Endoscopic Treatment
Three patients were successfully treated by PTCD. In two
patients, a stenosis was treated by transhepatic dilatation
and in one patient, bile leakage was treated by external
transhepatic stent insertion.
Forty patients (71.4%) were treated endoscopically
(Fig. 2). In 37 patients (66%), stent insertion was successful
and in three patients (5%), adequate drainage succeeded by
papillotomy. The median number of stent replacements was
five (range 1–15) with a median duration of treatment of
359 days (range 39–1,355). Complications occurred in nine
patients (24%). Stent dislodgment (n=3), clogging (n=2),
and cholangitis (n=5) were mild complications and were
successfully treated by stent exchange or administration of
antibiotics. One severe complication occurred in a 75-year-
old patient. After 4 years of stent therapy, the stent migrated
and perforated the duodenum. Finally, the patient died due
to multiple organ failure and sepsis.
Surgical Treatment
After referral and during the follow-up period, a new
hepatobiliary anastomosis was performed by hepaticojeju-
nostomy in 13 patients (23.2%). Mean duration of hospital
stay was 9.1±3.1 days. Postoperative complications oc-
curred in one patient (7.6%) who underwent a PTC
procedure after leakage of the anastomosis. No hospital
mortality occurred in patients who underwent a reconstruc-
tive procedure after a previous EEA.
Long-term Follow-up
After a mean follow-up of 7.1±3.3 years, seven patients
(13%) have died. One endoscopically treated patient died
due to a complication of treatment as described above. The
other patients died due to malignancy (n=4) and myocar-
dial infarct (n=2).
The long-term results in patients treated with endoscopic
and radiological treatment are as follows: from a total of 43
patients treated with endoscopic or PTCD procedures, 86%
(n=37) was successful. In three patients (7%), signs of
restenosis occurred after stent removal after 2, 3.5, and
4 months. Continued stent therapy was successful in all
three patients. Five patients underwent reconstructive
Figure 2 ERCP showing successful (aggressive) stent therapy after primary EEA. a Stenosis of the common bile duct. b Stents in situ. c After
stent removal within a year.
Table 2 Referral Pattern
Primary EEA
n=56 %
Time interval between injury and referral
Weeks, median (range) 16 (0–141)
Intervention after EEA and before referral
Explorative relaparotomy 2 4
Percutaneous drainage 5 9
Endoscopic stenting 12 21
Endoscopic papillotomy 9 16
PTD
a 24
Symptoms at referral
Cholestasis 14 25
Cholangitis/fever 10 18
Abdominal pain 15 27
Abces/biloma 4 7
Uncontrolled sepsis/peritonitis 3 5
Diagnosis at referral
Stenosis 38 68
Leakage 10 18
Combination of stenosis and leakage 8 14
Location of injury at referral
b
I9 1 6
II 21 38
III 17 30
IV 7 12
V2 4
aPercutaneous transhepatic drainage
bAccording to Bismuth classification
J Gastrointest Surg (2007) 11:296–302 299surgery after prolonged endoscopic stenting. Postoperative
complications occurred in two of the five patients and these
patients received additional therapy for wound infection
(n=1) and postoperative cholangitis (n=1).
The long-term results of surgical treatment after EEA are
as follows; from 13 patients who underwent a HJ after
work-up, a stenosis of the anastomosis occurred in two
patients (15%). Both patients underwent successful percu-
taneous transhepaticdilatation, respectively9and 35months
after surgery.
The overall 5 years stricture free survival in the total cohort
(n=56) is 91%, shown by a Kaplan Meier curve in Fig. 4.
Discussion
The present study describes a selected group of BDI
patients, who were referred for treatment after a complicat-
ed EEA. This group of patients is a negative selection,
representing the worst complications of EEA; otherwise,
patients were not referred for additional treatment. So, this
study does not provide any information about the success
rate of EEA. The present study shows a long-term stricture
free survival of 91% in EEA patients after treatment in a
tertiary center. The analysis showed that even the majority
of complications after primary AEE in a general hospital
can successfully be treated by endoscopic and radiological
interventions. In only one-third of the patients, a secondary
surgical repair is necessary. The surgical reconstruction
after EEA was associated with acceptable morbidity and
without mortality.
Around 40 to 45 patients are referred annually without
any sign of decrease over the last years. Considering 15.000
LC’s per year in the Netherlands, we still consider 0.4–
0.5% mentioned in the reviews as an underestimation of the
real incidence of BDI, at least in the Netherlands.
19 In 20%
of the patients referred to the AMC, the injury was detected
during the initial surgical procedure. This finding is similar
to reports in literature.
6,20 From the total of 500 referred
BDI patients, 11.2% was referred for the treatment of a
complication after peroperative EEA. Because referred
patients only represent the complications after EEA, we
do not know the real incidence of EEA procedures in BDI.
Peroperative repair in BDI detected during surgery can
be performed by EEA (with or without the use of a T-tube)
or by a primary HJ. A HJ is a more complex procedure and
End to end anastomosis 
n=56 (11.2%) 
Success n=32 (80%) 
Failure n= 8 (20%) 
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Radiological treatment (PTCD) 
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Figure 3 Flow diagram of the
success and failure rates after a
multidisciplinary treatment of
patients who underwent a pero-
perative end to end anastomosis
for bile duct injury. Given per-
centages are calculated from the
number of patients in the previ-
ous flow box. PTCD Percutane-
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Figure 4 Kaplan–Meier plot showing proportion of patients without
restenosis among 56 bile duct injury patients treated for complications
after EEA.
300 J Gastrointest Surg (2007) 11:296–302one shouldbeverycareful not tofurther extendthe injuryinto
the intrahepatic ducts or subsequently damage the arterial
supply (bleeding and clipping or ligation of right hepatic
artery).
21,22 The present study shows that if complications
occur after EEA, these can successfully be treated by
percutaneous or endoscopic balloon dilatation and/or stent-
ing in the majority of patients. A HJ in the acute setting
without dilated bile ducts is even more difficult and therefore
consulting a surgeon with experience in reconstructive
hepatobiliary surgery is recommended. In contrast with a
primary HJ an EEA is a relatively simple procedure and can
also be performed in less experienced hands. The risk to
increase damage is smaller in an EEA procedure and with
the use of a T tube instant bile drainage is realized. If
indicated, reconstructive surgery by means of an elective HJ
can be performed. It is strongly advised to perform a HJ after
classification the injury and analyzing the biliary anatomy.
Preoperative cholangiography (with the use of the T tube)
will illustrate the location of the stenosis and the extension of
dilation of the proximal bile ducts. A reconstructive
procedure for stenosis of EEA has a satisfying outcome, as
peroperative conditions are good after the inflammation has
subsided and the bile ducts are dilated due to stenosis.
In a situation in which peroperative bile leakage is due to
(extensive) tissue loss, in particular, in patients with more
proximal lesions at the bifurcation or intrahepatically, no
primary repair should be performed. In this situation,
adequate drainage of the upper right abdomen is strongly
advised and the patient should be referred for elective
reconstruction. Referral to tertiary center in this situation
has a positive effect on outcome.
2
End-to-end anastomosis is reported to be associated with
a high incidence of recurrent jaundice due to stricture
formation of the anastomotic area.
15 Therefore, some
authors suggest that EEA is almost never appropriate if
the bile duct has been completely transected,
15,23 while
others favor this strategy when there is no extensive tissue
loss.
18 Stent therapy for iatrogenic bile duct strictures has
changed during the last decade and therefore the long-term
outcome after stenting has improved.
24 A more aggressive
approach with more stents and smaller time intervals
between stent changes is favored. With this new approach,
80% of the patients who undergo an ERCP for postoper-
ative bile duct stenosis, have a 10-year stricture-free
survival.
25 Although complications occur at a significant
rate, these are usually mild. The only severe complication
occurred in the present series, due to a migrated stent, was
not reported in previous series.
24,25 After stent removal,
recurrent stenosis develops in 20% of patients within
2 years of stent removal.
25 Therefore, endoscopic treatment
should be the initial management of choice for postopera-
tive bile duct strictures. Without signs of improvement after
endoscopic stenting, reconstructive surgery is indicated in
otherwise fit patients.
Of interest is the evaluation of the long-term stricture-
free survival after treatment for complications after EEA.
After a mean follow-up of 7.1 years, restenosis after
treatment developed in 9% of the patients. In all patients
who underwent initial endoscopic therapy, restenosis oc-
curred a relatively short time after stent removal, diagnosed
within 2 to 8 months follow-up. Therefore, endoscopic
treatment is not associated with a high rate of long-term
restenosis after stent removal. In two patients, a restenosis
occurred within 3 years after a hepaticojejunostomy.
Symptoms were cholestasis and cholangitis. In both
patients, transhepatic dilatation was successful to resolve
the stenosis. The long-term stricture-free survival of 91% in
the present series provides evidence for a good outcome
after treating complicated EEA patients. If BDI is detected
during surgery, in particular if there is no extensive tissue
loss, the local anatomy is clear and there is no inflammation,
EEA could be considered as a sufficient treatment strategy.
Patients with postoperative complications (stricture or
leakage) should be treated by a multidisciplinary team of
gastroenterologists, radiologists, and surgeons. Postopera-
tive complications can adequately be managed by endo-
scopic or percutaneous drainage in two-third of the patients.
Reconstructive surgery after a complicated EEA is associ-
ated with low morbidity and no mortality.
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